I
nflammatory cytokines produced by the innate immune system after infection are critical for control of pathogen replication as well as for enhancing host APC functions. Importantly, these inflammatory cytokines also act directly on pathogen-specific CD8 T cells to modulate all phases of the T cell response (1) . Inflammatory cytokine signaling through receptors expressed by CD8 T cells is critical to promote their proliferation, survival, and differentiation into effector cells both in vitro and in response to infection (2-7). Furthermore, IFN-␥ produced in response to infection regulates the program of CD8 T cell contraction (8, 9) .
Recent studies also suggest that inflammatory cytokines such as IL-12 regulate memory CD8 T cell formation through a gradient of T-bet expression (10, 11) . Moreover, the rate at which CD8 T cells acquire memory characteristics, such as CD127 and KLRG-1 expression profiles, IL-2 production, and the ability to vigorously expand following booster immunization, is also controlled by inflammatory cytokines (12) . For example, the acquisition of phenotypic and functional memory CD8 T cell characteristics takes several months after clearance of acute infection (13) . In contrast, the time between priming and acquisition of memory characteristics is shortened to days in CD8 T cells responding to dendritic cell (DC) 3 immunization, which induces substantially less inflammation compared with infection (12) . Importantly, induction of inflammatory cytokines by administration of TLR agonists at the time of DC priming prevented the early acquisition of memory characteristics by the responding CD8 T cells (12) . Naive CD8 T cells specific for any given peptide-MHC complex constitute a very small fraction of the preimmune repertoire (14 -17) and these cells are distributed throughout the host blood system and secondary lymphoid organs. Several studies suggest that ϳ2 days after infection or DC immunization are necessary to activate the majority of naive Ag-specific precursors, whereas production of inflammatory cytokines is initiated within hours after infection (18 -20) . Thus, naive CD8 T cells could be exposed to inflammatory cytokines before, during, or after their interaction with activating APCs and it is unclear how the timing of cytokine exposure will influence the process of memory differentiation. Furthermore, in the case of any pathogen encounter, naive CD8 T cells that are not specific to that infection would be exposed to the inflammatory cytokines without being stimulated by their cognate Ag. It is unknown how exposure of naive CD8 T cells to inflammatory cytokines would influence subsequent responses to Ag stimulation. In this study, we document that DC immunization drives CD8 T cells through a transient effector phase to a default pathway of memory differentiation. Our results also define a window during the proliferative expansion phase when inflammatory cytokines are capable of influencing the rate that CD8 T cells acquire memory characteristics by sustaining effector differentiation. Thus, the timing of inflammatory cytokine exposure is critical in controlling the rate of memory CD8 T cell differentiation.
Materials and Methods
Mice C57BL/6 (B6, Thy1.2) were from the National Cancer Institute. OT-I (OVA 257 -specific)-transgenic Thy1.1 were previously described (21) . TLR9 Ϫ/Ϫ mice on a B6 background were a generous gift from Dr. J. Kline (University of Iowa, Iowa City, IA). Pathogen-infected mice were housed in appropriate biosafety conditions. Mice were used at 6 -10 wk of age. All experiments were approved by the University of Iowa Institutional Animal Care and Use Committee.
Dendritic cells
Splenic DC were isolated after s.c. injection of B6 mice with 5 ϫ 10 6 B16 cells expressing Flt3L (provided by M. Prlic and M. Bevan, University of Washington, Seattle, WA). When tumors were palpable (5 ϫ 5 mm), mice were injected with 2 g of LPS (Sigma-Aldrich) i.v. to mature the DC. Spleens were harvested 16 h later and were digested with DNase and collagenase for 20 min at 37°C/7% CO 2 with shaking (120 rpm). Spleen pieces were smashed through a nylon cell strainer (70 m) to generate a single-cell suspension, RBC were lysed, and splenocytes were resuspended in two parts of 10% FCS/RPMI 1640 to one part B16-Flt3L conditioned medium plus rGM-CSF (1000 U/ml) plus 2 M OVA 257-264 and incubated for 2 h at 37°C/7% CO 2 with shaking (100 rpm). Spleen cells were washed three times and CD11c ϩ cells were isolated using anti-CD11c microbeads (Miltenyi Biotec). The purity and activation status of DC were determined by staining for CD11c, CD86, and MHC class II. Routinely, Ͼ90% pure CD11c ϩ DC were obtained and the yield was ϳ15-20 ϫ 10 6 DC/mouse. DC were resuspended in saline and injected i.v.
Bacteria
Listeria monocytogenes expressing OVA 257-264 (LM-OVA) (22) and attenuated (actA-deficient) LM-OVA (19) were grown, injected 1 ϫ 10 5 CFU i.v. per mouse for primary infection or 1 ϫ 10 7 CFU i.v. per mouse for boosting, respectively, and quantified as previously described (12) .
Adoptive transfer experiments
Thy1.1 OT-I were obtained from the blood of naive donors and the number of input OT-I was calculated as previously described (23) . Approximately 500 Thy1.1 OT-I cells were transferred into each naive Thy1.2 B6 recipient mouse. These mice were injected with CpG oligonucleotide 1826 (Coley Pharmaceutical Group) i.p. (100 g) at different time points relative to DC immunization as described (see Fig. 2 ). All mice were immunized with ϳ1 ϫ 10 6 OVA 257 -coated matured DC at day 0. To measure proliferation, BrdU (BD Pharmingen) was injected i.p. (2 mg/mouse) and mice were kept on drinking water containing BrdU (0.8 mg/ml) (Sigma-Aldrich) for the indicated intervals. Detection of BrdU incorporation was performed according to the manufacturer's protocol (BrdU Flow Kits; BD Pharmingen).
Quantification and phenotypic analysis of Ag-specific T cells
The magnitude of the epitope-specific CD8 T cell response was determined either by intracellular IFN-␥ staining (ICS) or tetramer staining as previously described (18) or by staining for Thy1.1 marker exclusively expressed on transferred TCR-transgenic (tg) cells (23) . For analysis of circulating TCR-tg T cells, ϳ50 l of blood was obtained from each mouse. Phenotypic analysis was performed on Thy1.1 ϩ TCR-tg CD8 T cells. The number of TCR-tg T cells (Thy1.1 ϩ CD8) was presented as frequency of total PBL.
Abs, peptides, and MHC class I tetramers
Abs of the indicated specificity with appropriate fluorochromes were used. The following Abs were from eBioscience: IFN-␥ (XMG1.2), CD8 (53-6.7), CD127 (A7R34), KLRG1 (2F1), CD11c (N418), CD86 (GL-1), MHC II (I-A/I-E) (M5/114.15.2), isotype control rat IgG2a (eBR2a), rat IgG2b (KLH/G2b-1-2), Armenian hamster IgG, and Golden Syrian hamster IgG. The following Abs were from BD PharMingen: CD11c (HL3) and Thy1.1 (OX-7). The following Abs were from Caltag Laboratories: anti-human granzyme B and isotype control mouse IgG1. OVA 257-264 peptide was described elsewhere (21) . MHC class I tetramers (K b ) specific for OVA [257] [258] [259] [260] [261] [262] [263] [264] were prepared using published protocols (24, 25) .
Serum cytokine quantification
Serum (ϳ25 l) was obtained via retro-orbital bleeding at 0, 6, 12, and 48 h after CpG treatment. Serum IL-12p70, IL-6, IL-10, and GM-CSF were measured using Bio-Plex Mouse Cytokines Assays (Bio-Rad) and read on the Bio-Rad Bioplex 200 system. 
In vivo cytolytic assay

Results
TLR9 expression by the immunizing DC and responding CD8 T cells is not necessary for CpG oligodeoxynucleotide (ODN) to regulate memory differentiation
Injection of CpG ODN at the time of DC priming prevents early acquisition of memory characteristics by the responding CD8 T cells (12) . It is unknown whether the CpG ODN regulate CD8 T cell differentiation by signaling directly through TLR9 expressed by the immunizing DC or the responding CD8 T cells or indirectly through other host cells. To address this question, we needed an experimental system such as adoptive transfer of TCR-tg T cells where we could control TLR9 expression in various cell types. To verify that adoptive transfer of low numbers of OT-I TCR-tg cells specific for the OVA 257 peptide can serve as a reliable model for endogenous CD8 T cell responses after DC immunization, we transferred ϳ500 naive Thy1.1 OT-I cells into naive Thy1.2 C57BL/6 recipient mice and immunized them the next day with ϳ1 ϫ10 6 LPS-matured, OVA 257 -coated splenic DC with or without coinjection of CpG ODN 1826, a TLR9 agonist. The DC were obtained with high purity and they expressed appropriate costimulatory (CD86) and activation (MHC class II) markers (Fig. 1A) . On day 7 after DC immunization, we used peptide-stimulated ICS or direct ex vivo tetramer or allelic Thy1 marker staining to detect and enumerate both the OT-I and the OVA 257 -specific endogenous CD8 T cells in the PBL and spleen (Fig. 1, B-D) . Consistent with previous findings in our laboratory, the majority of OT-I cells responding to DC immunization exhibited a memory-like phenotype (CD127 high KLRG-1 low granzyme B low ) at day 7 after immunization (Fig. 1, E and F) . In striking contrast, OT-I cells responding to DC immunization in the presence of heightened inflammation (DC plus CpG) or to infection with LM expressing the OVA 257 peptide (LM-OVA) displayed an effector phenotype (CD127 low KLRG-1 high granzyme B high ) at day 7 after infection ( Fig. 1 , E and F) (12, 26, 27) . More importantly, this analysis revealed that expression of CD127, KLRG-1, and granzyme B was quite similar between OT-I and the endogenous OVA 257 -specific CD8 T cells in each immunization group (Fig. 1, E and F) . Furthermore, similar results were also obtained with different detection methods used (ICS or direct ex vivo tetramer and Thy1 staining).
To determine whether CpG signals directly through TLR9 expressed by the immunizing DC or responding OT-I cells, we analyzed the phenotypes and early booster response of wild-type (wt) OT-I cells that have been adoptively transferred into either wt or TLR9 Ϫ/Ϫ hosts. The hosts were then immunized with either OVA 257 -coated wt or TLR9 Ϫ/Ϫ LPS-matured DC in the presence or absence of CpG ODN injection ( Fig. 2A) . Both wt and TLR9
Ϫ/Ϫ DC were recovered with high purity as indicated by CD11c staining after purification and both populations exhibited similar levels of costimulation (CD86) and activation (MHC class II) markers (Fig. 2B) . Wild-type OT-1 cells responding to either wt or TLR9-deficient DC in wt hosts exhibited an accelerated memory phenotype (CD127 high KLRG-1 low ) at day 7 after immunization that was prevented by injection of CpG ODN in both groups (Fig. 2C, top two panels) . Thus, CpG ODN does not regulate memory CD8 T cell differentiation directly through TLR9 expressed by the immunizing DC. To address a potential role for OT-I-expressed TLR9, we repeated the experiment with TLR9-deficient recipients. CpG treatment failed to alter the phenotype of the responding wt OT-I cells at day 7 after priming with either wt or TLR9
Ϫ/Ϫ DC in the TLR9 Ϫ/Ϫ hosts. Since CpG treatment did not alter the phenotype of wt OT-I cells that were primed with TLR9 Ϫ/Ϫ DC in the TLR9 Ϫ/Ϫ hosts, we conclude that CpG does not act directly on the responding OT-I cells (Fig. 2C, bottom two  panels) . Interestingly, a recent study suggests that CpG ODN treatment influences responding CD8 T cells through their expression of the IL-12 receptor (28) . Our own preliminary data suggest further complexity and investigations of this and other specific cytokines in memory differentiation are ongoing (N.-L. L. Pham and J. T. Harty, unpublished data).
One of the operational and functional hallmarks of memory CD8 T cells is their robust proliferative response (boostability) upon re-exposure to Ag (29) . In the wt recipients, OT-I cells that were primed with either wt DC or TLR9 Ϫ/Ϫ DC in the absence of CpG-induced inflammation underwent substantial secondary proliferative response to early booster infection at day 7 with actAdeficient LM-OVA (att LM-OVA), consistent with their early memory-like phenotype. In contrast, OT-I cells that were primed with either wt DC or TLR9 Ϫ/Ϫ DC in the presence of CpG-induced inflammation failed to respond to early booster infection, consistent with their effector phenotype (Fig. 2D ). Consistent with their early memory-like phenotype, OT-I cells that were primed with wt DC either in the presence or in the absence of CpG in TLR9-deficient hosts underwent vigorous proliferative response after early booster infection, resulting in higher frequency of circulating OT-I in PBL (Fig. 2E) .
Taken together, these data show that CpG ODN does not regulate memory differentiation directly through TLR9 in the immunizing DC or responding CD8 T cells but rather acts indirectly through TLR9 expressed by host cells not directly involved in the priming event.
CpG induces inflammatory cytokines with distinct magnitudes and kinetics
CpG ODN stimulation of TLR9 in DC and B cells induces multiple cytokines in the host (30) . However, the kinetics and duration of various cytokines induced by CpG in the context of DC immunization are not defined. Thus, we next evaluated the systemic inflammatory cytokine milieu induced by DC immunization in the presence or absence of CpG ODN treatment. OT-I recipient wt mice were immunized with either DC or DC plus CpG at day 0. Sera were obtained at 0, 6, 12, 24, and 48 h after DC or DC plus CpG immunization for cytokine detection. To ensure that the measured cytokine profiles corresponded with the phenotype and function of the responding OT-I cells, we also analyzed the OT-I cells at day 7 after DC immunization and 5 days following booster infection with att LM-OVA administered on day 7 (Fig. 3A) . DC immunization alone did not induce detectable serum cytokine responses ( Fig. 3B and data not shown) . In contrast, DC immunization in the presence of CpG ODN induced multiple cytokines ( Fig.  3B and data not shown), which exhibited several distinct kinetic profiles. Serum IL-12p70, IL-6, IFN-␥, IL-10, and GM-CSF are representative of these different patterns following CpG treatment. Serum IL-12p70 peaked at 6 h, remained elevated for 12 h, and declined by 24 -48 h after CpG administration, while IL-6 also peaked at 6 h but declined quickly by 12 h after CpG treatment. IFN-␥, a cytokine that may regulate the CD8 T cell memory differentiation process (12), also exhibited a modest peak at 6 h after CpG treatment and then rapidly declined to baseline levels. Serum IL-10 did not peak until 24 h and remained elevated up to 48 h after CpG treatment, whereas serum GM-CSF levels were not elevated in response to CpG ODN (Fig. 3B) . The different inflammatory environments in the host between DC and DC plus CpG immunization clearly influenced the rate of memory differentiation of the responding OT-I cells as reflected by their phenotype and response following early booster infection. Consistent with the serum cytokine data, OT-I cells at day 7 after DC immunization displayed effector (CD127 low KLRG-1 high ) and memory-like phenotype (CD127 high KLRG-1 low ) and function (response to early booster infection) in the presence or absence of CpG ODN coinjection, respectively (Fig. 3, C and D) . Thus, at least some cytokines that are potentially capable of regulating CD8 T cell differentiation were only elevated for a short period of time (6 -24 h) after CpG ODN treatment.
Encounter with inflammatory cytokines before Ag-driven proliferation of CD8 T cells does not prevent accelerated memory generation
Two-photon microscopy studies in live animals showed that activation of naive T cells required DC-T cell interaction that occurred in three distinct phases and lasted for Ͼ20 h (31). In addition, another in vivo study demonstrated that the duration of Ag presentation by stimulating DC must be between 30 and 54 h to engender the full magnitude of the CD8 T cell response (20) . It is likely that some naive T cells encounter the immunizing DC shortly (hours) after vaccination while other naive T cells may be initially stimulated relatively late (24 -48 h) after immunization. Due to the kinetics of systemic cytokine induction by CpG ODN, naive CD8 T cells could be exposed to specific inflammatory cytokines before, during, or after their interaction with stimulating DC. Thus, we next determined the time window when such an inflammatory environment impacts the differentiation process of the responding CD8 T cells. The DC immunization strategy and CpG ODN approach offers the advantage of delivering a constant dose of Ag and costimulation while allowing us to modulate the timing of inflammatory cytokine induction.
Induction of inflammatory cytokines was achieved by injection of CpG in the OT-I recipient mice either 2 days before, at the time of (day 0), or 2 days after DC-OVA immunization (Fig. 4A) . Control OT-1 recipient mice were immunized with DC-OVA alone to generate the accelerated memory phenotype or infected with LM-OVA to generate cells with a conventional effector phenotype. At day 6 after immunization or infection, we analyzed the OT-I cells from PBL. Consistent with data obtained from the spleen (Fig. 1,  D and E) , OT-I cells in the PBL exhibited early memory-like phenotype (CD127 high KLRG-1 low granzyme B low ) at day 6 after DC immunization, but an effector phenotype (CD127 low KLRG-1 high -granzyme B high ) at day 6 after LM-OVA infection (Fig. 4B, f and  u, respectively) . Interestingly, inflammation induced by CpG ODN 2 days before DC immunization did not prevent the responding OT-I cells from early acquisition of memory-like characteristics at day 6 after immunization. The majority of OT-I cells in this group were CD127 high , KLRG-1 low , and granzyme B low even though they have been exposed to inflammatory cytokines induced by CpG before the encounter with the stimulating DC. In sharp contrast, inflammation induced by CpG at day 0 or day 2 after DC immunization had a significant impact on the phenotypes of these expanding OT-I cells. CD127 expression was down-regulated, KLRG-1 expression was up-regulated and a substantial fraction of OT-I cells expressed the cytolytic effector molecule granzyme B, consistent with an effector CD8 T cell phenotype (Fig. 4B) . It should be noted that we routinely observed enhanced CD8 T cell responses (2-to 4-fold; Figs. 1 and 4) when CpG ODN were injected at day 0 relative to DC priming. These results are consistent with the potential role of inflammatory cytokines such as IL-12 and type I IFN to act as signal 3 to promote survival of T cells during expansion (3-5, 7, 9, 32) . However, injection of CpG ODN day ϩ2 relative to DC immunization failed to increase expansion, although this approach had a substantial impact on the phenotype of the responding CD8 T cells. These data suggest that signal 3, promoting T cells survival during proliferation, can be separated from the impact of inflammatory cytokines on the memory differentiation program.
We also determined whether the timing of cytokine exposure regulated the ability of the stimulated OT-I cells to respond to an early booster immunization. Consistent with their phenotypes, OT-I T cells stimulated by DC underwent substantial secondary proliferative response to booster infection at day 6 with actA-deficient LM-OVA (Fig. 4C, left panel) , whereas the OT-I T cells in LM-OVA-infected mice failed to expand further in response to the early booster infection (Fig. 4C, right panel) . Although CpG treatment at day 0 or day ϩ2 prevented this early booster response similar to LM-OVA infection, CpG treatment at day Ϫ2 did not prevent this early booster-response (Fig. 4C, middle three panels) . Together, these data demonstrated that exposure of naive CD8 T cells to inflammatory cytokines before their interaction with the stimulating DC did not prevent the accelerated generation of memory CD8 T cells based on both phenotype and function. These results suggested that both the inflammatory cytokine(s) and the duration of inflammation potentially play important roles in regulating the CD8 T cell memory differentiation. Furthermore, inflammatory cytokines must be present during or after the priming phase to influence the rate by which CD8 T cells acquire memory characteristics.
Inflammatory cytokines exert the greatest impact on proliferating CD8 T cells
CD8 T cell priming by mature DC involves TCR and costimulatory molecule signaling that together stimulate proliferation of the activated T cells. Clonal expansion of pathogen-specific CD8 T cells after infection is also associated with differentiation to effector T cells that migrate throughout the body to defend against infection (1, 33) . These data suggest a link between proliferation and differentiation, where signals received during proliferation may program patterns of gene expression or epigenetic modifications that are restricted in nonproliferating cells. Thus, we next asked whether inflammatory cytokine signaling influences the rate of CD8 T cell memory characteristic acquisition most drastically during proliferation.
To address this possibility, we used BrdU incorporation to identify the fraction of OT-I cells that were proliferating during three defined time periods: days 4 -6, days 6 -8, and days 12-14 after DC-OVA immunization in control mice and those that received CpG on the first day of BrdU administration. The expression levels of CD127, KLRG-1, and granzyme B on the OT-I cells in the presence or absence of CpG treatment were evaluated on the last day of BrdU treatment for each group (Fig. 5A ). As expected, essentially all (Ͼ97%) of the OT-I cells incorporated BrdU between days 4 and 6 after DC immunization while only a fraction incorporate BrdU between days 6 and 8, a time interval that consists of the tail end of expansion and initial period of contraction. In contrast, the majority of OT-I cells did not incorporate BrdU between days 12-14, an early memory time point after the contraction phase (Fig. 5B) .
CpG treatment during days 4 -6 when all T cells were proliferating resulted in down-regulation of CD127 and up-regulation of KLRG-1 and granzyme B on the responding OT-I cells (Fig. 5C,  left panel) . Of note, these alterations are less pronounced than observed when the CpG ODN were administered at day 0 or ϩ2, and the T cells analyzed on day 7, likely due to the shortened interval of analysis in Fig. 5 . CpG ODN treatment during the day 12-to 14-period, where most OT-I cells did not proliferate, had minimal impact on the expression level of CD127, KLRG-1, and granzyme B on the OT-I cells (Fig. 5C, right panel) . Interestingly, CpG treatment resulted in less pronounced CD127 down-regulation and granzyme B up-regulation during the day 6-to 8-interval when only a fraction of OT-I cells were proliferating (Fig. 5C,  middle panel) . In this study, we did not observe dramatic changes in KLRG-1 expression since we restricted our analysis within the 48-h window following CpG treatment. This short time window may be insufficient to ensure full up-regulation of KLRG-1 following CpG treatment.
The day 6-to 8-interval provided a unique opportunity to examine the impact of CpG-induced inflammation on both proliferating and nonproliferating OT-I populations, which could be clearly identified by their ability to incorporate BrdU (Fig.  5B ). To directly analyze the effect of inflammation on proliferating and nonproliferating OT-I populations, we administered CpG on day 5 after DC immunization to allow the inflammation to take place before initiating BrdU treatment on days 6 through 8. Since the short exposure to CpG-induced inflammatory cytokines had the most significant effect on CD127 expression (Fig. 5C) , we examined surface expression of this marker on the BrdU ϩ and BrdU Ϫ fractions of the OT-I cells at days 7 and 8. Compared with the DC immunization alone, CpG-induced inflammation resulted in a much more substantial CD127 downregulation on the BrdU-positive compared with the BrdU-negative fractions (Fig. 5, D and E) . Taken together, these data suggest that CD8 T cell memory differentiation is most susceptible to inflammatory cytokine regulation when these cells are rapidly dividing.
A default pathway of memory CD8 T cell differentiation is deflected by encounter with inflammatory cytokines
Our previous study using supraphysiologic high-number OT-I adoptive transfers suggested that DC stimulation did not directly generate memory cells but rather the responding CD8 T cells exhibited some characteristics of effector populations (CD127 low , CD43 (1B11) high , and IL-2 low ) at early time points (12) . Several studies suggest that genetic or functional evidence for expression of effector molecules such as IFN-␥ or granzyme B indicates that memory T cells have passed though an effector phase (34 -36) . One possibility is that inflammatory cytokines are required to initiate the CD8 T cell effector differentiation program. Alternatively, inflammatory cytokines may act to enforce the effector differentiation program initiated by TCR stimulation and deflect a default pathway of memory CD8 T cell differentiation. To resolve these possibilities in a physiologic setting, we transferred ϳ500 naive Thy1.1 OT-I cells into Thy1.2 hosts and analyzed both the phenotype and functional cytolytic capacity of the OT-I cells at day 4 (ϳ90 h) following immunization with OVA 257 -coated DC in the presence and absence of CpG ODN coinjection. The OT-I cells were detectable in the spleens at days 4 and 7 following DC immunization (Fig. 6A) . Notably, the majority of OT-I cells at day 7 after DC immunization showed a memory phenotype (CD127 high KLRG-1 low granzyme B low ), whereas the OT-I cells at day 7 after DC plus CpG immunization showed an effector phenotype (CD127 low KLRG-1 high granzyme B high ) (Fig. 6, B and C) . In contrast, the majority of OT-I cells at day 4 after DC or DC plus CpG immunization showed similar effector phenotype, i.e., CD127 low and a similar frequency of cells expressing granzyme B (Fig. 6, B and C). KLRG-1 was not up-regulated in either population at this early time point. To address the functional capacity of these OT-I cells, we performed a 5-h in vivo cytolytic assay at day 4 following DC or DC plus CpG immunization. Similar small numbers of OT-I were detectable in the spleen in both groups at this early time point and consistent with their effector phenotype, both groups displayed similar in vivo killing capacity (Fig. 6, E and  F) , regardless of whether they were primed and/or expanded in the presence or absence of CpG-induced inflammatory cytokines. Similar proportions of OT-I cells from DC or DC plus CpG mice at day 4 after immunization also produced IFN-␥ after a short in vitro stimulation (data not shown). Taken together, these results suggest that CD8 T cells responding to DC immunization in the absence of inflammatory cytokines go through a transient effector phase, as demonstrated by both phenotype and function, but then undergo a default pathway rapidly leading to the expression of the phenotypic and functional characteristics of long-term memory populations. However, encounter with inflammatory cytokines deflects this default pathway of FIGURE 5. Inflammation exerts the greatest impact on memory differentiation during proliferation of CD8 T cells. A, Experimental design: naive B6 Thy1.2 mice received ϳ500 naive Thy1.1 OT-1cells and were immunized with OVA-coated DC 1 day later (day 0). BrdU was administered to individual groups of mice at three different time periods: days 4 -6, days 6 -8, and days 12-14. CpG was administered for some mice in each group at the beginning of each interval. Control groups received BrdU but no CpG treatment. OT-I cells from the spleen were analyzed at days 6, 8, and 14 from the respective groups. B, Representative histograms of BrdU incorporation by OT-I cells at various time intervals. Numbers on the right in the histograms represent the percentage of OT-I cells that incorporated BrdU during the 2-day period. C, The percentage (mean Ϯ SD, n ϭ 3) of OT-I cells in the spleen expressing CD127, KLRG-1, and granzyme B from the DC and DC ϩ CpG groups in the three time periods of BrdU treatment (days 4 -6, days 6 -8, and days [12] [13] [14] . D, Representative histograms of isotype staining and CD127 expression on BrdU ϩ and BrdU Ϫ fractions of OT-I cells at day 8 after DC priming either in the presence or absence of CpG administered to the hosts on day 5. Shaded and unshaded histograms represent DC immunization and DC ϩ CpG groups, respectively. The top two panels are from the BrdU-negative OT-I population and bottom two panels are from the BrdU-positive OT-I. Top and bottom (in parentheses) numbers indicate the frequency of OT-I cells expressing CD127 in the absence or presence of CpG, respectively. E, Normalized percentage of reduction in CD127 expression of both BrdU-negative and BrdU-positive OT-I populations is calculated as followed: (100% Ϫ ((percent CD127-positive OT-I on DC ϩ CpG)/(percent CD127-positive OT-I on DC only)) on both days 7 and 8 following DC either in the presence or absence of CpG administered to the hosts on day 5. Statistical analysis was performed with the Student t test. CD8 T cell memory differentiation toward a sustained effector differentiation program. Therefore, we concluded that inflammatory cytokines are not required to initiate the CD8 T cell effector differentiation program, but they rather serve to enforce this program at the expense of a default CD8 T cell memory differentiation after DC immunization.
Model
Based on the data from this study, we propose a model to explain how the timing of inflammatory cytokine signaling to the CD8 T cells critically controls the rate at which these cells acquire memory characteristics. DC immunization activates naive CD8 T cells to undergo proliferation and undergo gene expression changes (down-regulation of CD127, up-regulation of the 1B11 Ab epitope on CD43 (12), increased ability to produce IFN-␥ and granzyme B, this study) that are characteristic of an effector population. However, in the low inflammation environment of DC immunization, this effector phenotype is not stable and the responding CD8 T cells default to a differentiation program where they rapidly acquire the phenotype and functional characteristics of long-term memory populations as they continue to proliferate (Fig. 7A) . The timing of exposure of inflammatory cytokine signals to the CD8 T cells is critical in controlling the rate of memory generation since neither exposure of inflammatory cytokines to naive nondividing CD8 T cells before stimulation nor late exposure of inflammatory cytokines to Ag-experienced CD8 T cells that have ceased rapid division modulates the phenotype and function of the responding CD8 T cells (Fig. 7B) .
In contrast, in an acute bacterial or viral infection or DC immunization in the presence of TLR agonist-induced inflammation, FIGURE 6. The default pathway of memory CD8 T cell differentiation is deflected by encounter with inflammatory cytokines. Naive B6 Thy1.2 mice received ϳ500 naive Thy1.1 OT-I cells. Mice were immunized with ϳ1 ϫ 10 6 OVA 257-264 -coated DC in the presence or absence of CpG coinjection (ϳ100 g i.p.). A, Analysis of OT-I cells in the spleen from a representative mouse from each group (DC and DC ϩ CpG) at days 4 and 7 following DC immunization. B and C, Phenotypic analysis of naive OT-I cells (day 0) and responding OT-I cells at days 4 and 7 following DC immunization in the presence or absence of CpG ODN coinjection. B, Representative histograms and C, kinetics of CD127, KLRG-1, and granzyme B expression by OT-I cells. D, Number of total OT-I cells recovered from the spleen of mice immunized with DC or DC ϩ CpG; n.s., Not statistically significant by the Student t test. E and F, In vivo cytolytic assay: at day 4 following immunization with either DC or DC ϩ CpG, OT-I recipient mice or naive control mice that received neither OT-I nor DC were injected with target cells consisting of 10 ϫ 10 6 CFSE high -labeled B6 splenocytes (no peptide) and 10 ϫ 10 6 CFSE low -labeled B6 splenocytes (coated with OVA 257 peptide). E, Representative histograms of CFSE-labeled cells recovered from each group at 5 h after target cell injection. Number in the histogram is the percentage of the CFSE low population remaining after 5 h. F, Percent specific killing calculated by the formula described in Materials and Methods. Cumulative data are from three mice per group.
heightened inflammation is present during the period of priming and expansion where the responding CD8 T cells are proliferating robustly. Rapidly dividing CD8 T cells are more susceptible to inflammatory cytokine signaling, which promotes and sustains their effector differentiation program and prevents their early acquisition of memory characteristics (Fig. 7C) . This model provides a framework to address in detail how inflammatory cytokines regulate the molecular pathways (gene expression and epigenetic modifications) that dictate CD8 T cell memory differentiation.
Discussion
During an immune response, CD8 T cells must integrate a variety of inputs, including the inflammatory signals generated by the infection that ultimately determine their eventual fate (10, 12, 18, 32, 37, 38) . Recent studies from our laboratory have demonstrated that reducing or truncating the inflammatory environment in the host during an immune response accelerated the process of CD8 T cell memory differentiation on the population level (12, 37) . Thus, the rate of memory CD8 T cell generation is not fixed in time but rather regulated by exposure to inflammatory cytokine signals.
Since there exists a strong correlation between the number of memory CD8 T cells and the level of protection, an understanding of how the host environment influences the differentiation of these memory CD8 T cells may suggest ways to favorably manipulate memory generation (39 -41) . However, it is unclear when and how the inflammatory signals regulate the memory differentiation process. In this study, we define the time window where the inflammatory signals in the host are crucial in controlling the rate of CD8 T cell memory differentiation. Our results show that CD8 T cells responding to DC immunization undergo a default pathway of memory differentiation that can be deflected toward sustained effector commitment by encounter with inflammatory cytokines. Furthermore, the inflammatory signals exert the greatest impact on the actively proliferating CD8 T cell population.
The DC immunization model allowed us to dissociate the early priming events involving signal 1 (TCR:peptide-MHC complex) and signal 2 (costimulation) from inflammatory signals that act either directly or indirectly on the responding CD8 T cells to regulate their memory differentiation process. Inflammatory cytokines such as IL-12, type I IFNs, and IFN-␥ have been identified to serve as signal 3 for effector CD8 T cell survival during proliferation (1, (3) (4) (5) (6) (7) . Although we did observe a greater accumulation of Ag-specific CD8 T cells at the peak of expansion when CpG ODN were codelivered with the immunizing DC at day 0, CpG ODN administered at 2 days after DC immunization did not enhance CD8 T cell expansion compared with DC immunization alone (Fig. 4C) . However, inflammatory cytokines induced by CpG ODN delivered day 2 after DC immunization still blocked the acquisition of early memory phenotype and function by the responding CD8 T cells. These results strongly suggest that inflammatory cytokines not only can play a role as signal 3 but also serve a distinct function to regulate the CD8 T cell memory differentiation process. Identification of the specific cytokines that regulate memory differentiation remains an active area of investigation in our laboratory.
A strong inflammatory response accompanying an acute infection is often beneficial to the host to mature the APCs, to inhibit pathogen replication, and to promote the development of a robust effector T cell response. However, naive CD8 T cells that are not specific for this infection will also be exposed to the inflammatory environment generated by the infection itself. In this study, we asked whether such exposure might alter differentiation of these cells in response to DC immunization shortly after being exposed to the inflammatory environment. Our results show that the inflammatory cytokines do not alter the memory differentiation potential of naive CD8 T cells nor adversely impact preexisting early memory CD8 T cells even though these cells are potentially exposed to inflammatory environment multiple times during the life of the host. An interesting question that remains is why inflammatory cytokines do not influence the naive CD8 T cell memory differentiation in response to subsequent Ag stimulations? It is possible that naive CD8 T cells do not express the appropriate cytokine receptors and thus do not respond to the inflammatory cytokine(s) until these receptors are up-regulated after Ag stimulation. At least some of the receptors (such as type I IFNR or type II IFNR) for CpG-induced inflammatory cytokines are constitutively expressed (42) (43) (44) (45) , whereas as other receptors (such as IL12 or IL-18) may be induced by activation (46 -49) . Moreover, it is also possible that inflammatory cytokine signaling must be integrated with signal 1 and signal 2 to ensure the full development of the CD8 T cell effector program. Synergy between inflammatory cytokines and TCR signaling has been well documented in CD4 T cell polarization. For example, although the IL-12 receptor is undetectable on most resting T cells, activation through the TCR and costimulatory interactions induces the transcription and expression of both chains of IL-12 receptor (48, 50) . However, IL-12-responsive T H 1 cells further up-regulate the IL-12R␤2 chain in response to IL-12 and IFN-␥ while T H 2 cells down-regulate the IL-12R␤2 chain in response to IL-4 (46). Thus, it seems that naive, unstimulated T cells or preexisting memory T cells largely ignore the cytokine milieu produced in response to unrelated pathogens. In this way, only the differentiation of the responding T cells would be shaped by the particular pathogen-specific inflammatory cytokines produced during infection. This scenario would prevent previous infections from skewing subsequent T cell responses, thus preserving flexibility to mount the appropriate responses to new pathogens.
How do inflammatory cytokines regulate the delicate balance between effector and memory CD8 T cell differentiation? It must be emphasized that the responding CD8 T cells that are primed and/or expanded in the low inflammatory environment (i.e., DC immunization) underwent a transient effector phase but they acquired phenotypic and functional memory features at an accelerated rate. Our data showed that inflammatory cytokines exert the greatest impact on vigorously proliferating cells. Thus, we propose that CD8 T cells initially differentiate into effector cells after receiving TCR and costimulatory signals from activated APCs but will undergo a default memory differentiation program unless they encounter inflammatory cytokines, which play a critical role in sustaining the effector differentiation program by the responding CD8 T cells. Our model predicts that specific inflammatory signals generated during the immune response to infection do not initiate the effector differentiation program but rather enforce and sustain such a program to its fullest potential. Moreover, our model incorporates the contribution of inflammatory signals that must be present during the priming and/or expansion phase of the CD8 T cells as a critical regulator of the CD8 T cell memory differentiation. Our results are consistent with recent published works suggesting that inflammation regulates the CD8 T cell effector differentiation program (6, 7, 10) . CD8 T cells that are primed and/or expanded in the presence of a heightened inflammatory milieu exhibited an effector phenotype (CD127 low KLRG-1 high granzyme B high ). These cells have been characterized as short-lived effector cells (10) , which failed to further robustly expand in response to early booster immunization (12, 37) .
The differentiation of naive CD4 T cells into polarized effector cells resulted in epigenetic modifications such as demethylation and histone acetylation at several gene loci (51, 52) . Similarly, the CD8 differentiation from naive to effector to memory cells is associated with unique changes in chromatin structure and patterns of gene expression (13, 38, 53, 54) . More importantly, such differentiation processes are linked to cell division. The rate of CD8 T cell division during the robust expansion phase has been estimated to be as rapid as 6 h per cell division (23, 55) . During rapid replication, chromatin structures remain in an open configuration to permit access to the replication machinery. Our data suggest that the proliferating cells are more responsive to undergo phenotypic and functional changes induced by inflammatory cytokines than are their nonproliferating counterparts. Perhaps, the proliferating cells possess a more permissive chromatin configuration for epigenetic modifications imposed by inflammatory signals. These ideas may explain, in part, why exposure of naive circulating CD8 T cells that do not proliferate vigorously to inflammatory cytokines before their encounter with stimulating DC failed to prevent their early acquisition of memory characteristics. One interesting question that arises is whether there also exists a transcriptional "master regulator" or a transcriptional network whose activity is influenced by inflammatory signals that regulates memory CD8 T cell differentiation? Identifying such a regulator or network will provide valuable insight into the molecular basis of memory CD8 T cell generation. The model system of DC immunization and timed addition of CpG ODN-induced cytokines may prove valuable in dissecting these possibilities.
The ultimate goal of the CD8 T cell immune response is to expand in number and differentiate appropriately to fight the inciting pathogen and form memory cells to guard against reinfection. Our data show that interaction of naive CD8 T cells with Ag-expressing mature DC provides sufficient stimulation to drive T cell proliferation and for the responding T cells to undergo changes in gene expression consistent with an effector phenotype and function. However, in the absence of encounter with inflammatory cytokines, this effector commitment is transient and the responding CD8 T cells default to a differentiation program that rapidly promotes acquisition of memory characteristics as they further proliferate. Encounter with inflammatory cytokines during this rapid proliferative phase efficiently deflects differentiation away from memory toward a sustained effector program. Thus, the inflammatory cytokine response elicited by infection serves as the endogenous danger signals to alert the host to mount an appropriate immune response by shaping the T cell differentiation program. These danger signals participate in the CD8 T cell response not only by maturing professional APCs to deliver the activation signals to CD8 T cells, but also by enforcing the appropriate effector differentiation program to ensure that sufficient resources are devoted to clearance of the inciting pathogen.
